$ Value
$0
Shares
71,254
Price
$0
Filed
Jun 17
Insider
Name
Hare Joshua
Title
Chief Scientific Officer
CIK
0001449392
Roles
Transaction Details
Transaction Date
2025-06-13
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
71,254
Footnotes
The option will 100% cliff vest on July 1, 2025. The option was administratively granted on March 4, 2025 contingent on stockholder approval at the 2025 Annual Meeting of Stockholders (the "Annual Meeting"). This Form 4/A re-reports an option disclosed in a previous Form 4, filed on March 6, 2025 to (i) correct the transaction date, which was mistakenly reported as March 4, 2025 and (ii) report that the stockholder approval contingency relating to an increase in the number of shares available for awards under the Company's 2021 Incentive Award Plan (as amended and restated to date) was satisfied upon approval of the share increase at the Annual Meeting held on June 13, 2025.
Filing Info
Hare Joshua's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-15 | LGVN | A | $0 |
| 2025-07-01 | LGVN | A | $0 |
| 2025-06-13 | LGVN | A | $0 |
| 2025-06-13 | LGVN | A | $0 |
| 2025-05-16 | LGVN | ▼ | $7K |
Other Insiders at LGVN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Willard Stephen H
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Lehr Paul T
General Counsel, Secretary
|
— | — | 2026-04-01 |
|
Agafonova Nataliya
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Locklear Lisa
Chief Financial Officer
|
— | — | 2026-04-01 |
|
Blass Devin
CTO & SVP of CMC
|
— | — | 2026-04-01 |